Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Haddad

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
BMJ Case Reports|April 15, 2025
Neurofibromatosis associated with anorexia nervosa and attention-deficit hyperactivity disorderMurray Glen Tucker, Peter M Haddad
Journal of Psychopharmacology (Oxford, England)|May 11, 2012
Challenges in the management of early psychosisPeter M Haddad, Imran B Chaudhry
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 17, 2004
Re: Depression, stroke diagnosis, and SSRI discontinuation syndromePeter M Haddad, Serdar M Dursun
Journal of Affective Disorders|August 4, 2009
CANMAT guidelines for depression: clear and user-friendlyIan M Anderson, Peter M Haddad
Convulsive Therapy|January 1, 1993
Electroconvulsive Therapy-Related Psychiatric Knowledge Among British AnesthetistsPeter M. Haddad, Susan M. Benbow
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 16, 2011
Prescribing antidepressants for depression: time to be dimensional and inclusiveIan M Anderson, Peter M Haddad
Human Psychopharmacology|December 22, 2007
Neurological complications of psychiatric drugs: clinical features and managementPeter M Haddad, Serdar M Dursun
Human Psychopharmacology|December 22, 2007
Improving drug safety and tolerability in psychiatric clinical practicePeter M Haddad, Serdar M Dursun
Therapeutic Advances in Psychopharmacology|October 23, 2018
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analysesPeter M Haddad, Christoph U Correll
Expert Opinion on Pharmacotherapy|March 15, 2023
Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challengesPeter M Haddad, Christoph U Correll
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
BMJ Case Reports|April 15, 2025
Neurofibromatosis associated with anorexia nervosa and attention-deficit hyperactivity disorderMurray Glen Tucker, Peter M Haddad
Journal of Psychopharmacology (Oxford, England)|May 11, 2012
Challenges in the management of early psychosisPeter M Haddad, Imran B Chaudhry
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 17, 2004
Re: Depression, stroke diagnosis, and SSRI discontinuation syndromePeter M Haddad, Serdar M Dursun
Journal of Affective Disorders|August 4, 2009
CANMAT guidelines for depression: clear and user-friendlyIan M Anderson, Peter M Haddad
Convulsive Therapy|January 1, 1993
Electroconvulsive Therapy-Related Psychiatric Knowledge Among British AnesthetistsPeter M. Haddad, Susan M. Benbow
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|March 16, 2011
Prescribing antidepressants for depression: time to be dimensional and inclusiveIan M Anderson, Peter M Haddad
Human Psychopharmacology|December 22, 2007
Neurological complications of psychiatric drugs: clinical features and managementPeter M Haddad, Serdar M Dursun
Human Psychopharmacology|December 22, 2007
Improving drug safety and tolerability in psychiatric clinical practicePeter M Haddad, Serdar M Dursun
Therapeutic Advances in Psychopharmacology|October 23, 2018
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analysesPeter M Haddad, Christoph U Correll
Expert Opinion on Pharmacotherapy|March 15, 2023
Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challengesPeter M Haddad, Christoph U Correll
Pageof 10